Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News


Facebook Twitter LinkedIn Email Comments
The FDA has approved the CustomVue monovision lasik device from AMO/Visx Inc. of Santa Clara, Calif. The product is designed to fully correct nearsightedness in the patient’s dominant eye but only partially correct it in the nondominant one, allowing patients to view both nearby and distant objects after an adjustment period. In contrast to traditional lasik, the procedure may reduce the need for patients over the age of 40 to wear reading glasses.

Sep 2007
BiophotonicsFDALASIKNews & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.